| MCVAX | VMVIX | MCVAX / VMVIX | |
| Total Expense Ratio | 1.19 | 0.19 | 626% |
| Annual Report Gross Expense Ratio | 1.19 | 0.19 | 626% |
| Fund Existence | 12 years | 19 years | - |
| Gain YTD | 8.428 | 9.024 | 93% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 932M | 31.8B | 3% |
| Annual Yield % from dividends | 1.02 | 2.02 | 51% |
| Returns for 1 year | -6.03 | 0.92 | -658% |
| Returns for 3 years | 1.69 | 24.50 | 7% |
| Returns for 5 years | -1.69 | 51.17 | -3% |
| Returns for 10 years | 4.86 | 101.93 | 5% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VLU | 209.33 | 0.39 | +0.18% |
| State Street® SPDR® S&P® 1500 ValTiltETF | |||
| SYFI | 35.88 | 0.05 | +0.13% |
| AB Short Duration High Yield ETF | |||
| TCAF | 38.38 | -0.10 | -0.27% |
| T. Rowe Price Capital Apprec Eq ETF | |||
| SAMM | 30.17 | -0.12 | -0.38% |
| Strategas Macro Momentum ETF | |||
| MVV | 69.07 | -0.42 | -0.60% |
| ProShares Ultra MidCap400 | |||